Name: 2026 SDCASEA Annual Banquet
Start: 2026-02-28T11:30:00-08:00
End: 2026-02-28T15:00:00-08:00
Location: The Heights Golf Club

Join SDCASEA and Dr. Gene Lay (賴正光博士) Founder, President, and Chief Executive Officer 分享他在生物科技的人生經歷
About this Event

科工會將於2月28日在 The Heights Golf Club 舉辦第四十三屆年會。我們非常榮幸邀請了知名的生物科技學者與企業家賴正光博士主講 " 我的生物科技之旅“ – 賴博士將分享他在生物科技的人生經歷。

會議時間:

報到及交誼時間於11:30am開始
年會從 12pm到3pm

票價:

SDCASEA Member (會員), $50
General Ticket (非會員), $60
Student (學生), $50

購票方式:

由於我們需要正確人數，以供餐廳提供餐點，因此需要事先繳費，不接受現場報名

［方式一］您也可以直接與科工會的任何一位理事購票及選擇您的餐點

或者，

［方式二］您可繼續選擇餐點，然後zell to "[email protected]"
＊請注意，需完成繳費才視為成功報名，不接受當日收費，若您有報名問題，請洽 [email protected]

餐飲選項：

我們提供 3-Course Platted Lunch。除了有Salad，以及甜點之外，主餐選項包括：

Airline Chicken Breast (Roasted Fingerling Potatoes, Baby Carrots, Pan Gravy)
Pan Roasted Scottish Salmon (Seasonal Squash Succotash, Arugula, Beurre Rouge)
Portobello Mushroom Stack (Vegetarian) (Heirloom Tomatoes, English Peas, Baby Squashes, Lemon-Caper Sauce)

其他注意事項：

*購票將於2月24日截止，之後科工會將無法接受退款，但可接受票據轉讓。

本活動由中華民國僑務委員會贊助，十分感謝大家的參與，祝您新春如意、大吉大利！

Thank you kindly,

SDCASEA Committee

賴正光博士簡介：

Gene Lay, M.S., D.V.M.

Founder, President, and Chief Executive Officer

賴正光博士（Dr. Gene Lay）是知名的生物科技企業家，現任 Senior VP, Life Sciences at Revvity。身為一位科學家與企業領導者，賴博士帶領團隊負責規劃與發展公司生命科學產品組合，並提供創新解決方案，以加速各治療領域中突破性研究成果的實現。

2002 年 6 月，賴博士在美國加州聖地牙哥創立 BioLegend，專注於開發和生產高品質抗體、蛋白質和試劑，服務於細胞免疫、炎症、癌症、幹細胞與其他生醫研究領域，並自 2003 年 1 月起擔任 BioLegend 的總裁暨執行長。並於 2021 年 7 月被 PerkinElmer收購，後來 PerkinElmer 轉型為 Revvity, Inc.，BioLegend 也成為 Revvity 的一部分，而賴博士因此加入 Revvity 擔任 Senior VP, Life Sciences，負責生命科學產品策略與業務發展。在創立 BioLegend 之前，賴博士於 1987 年共同創辦 PharMingen, Inc.，該公司十年後被 BD Biosciences 收購，他也擔任營運副總裁至 2002 年。

賴博士對免疫學的熱忱源於其學術背景，這份熱情貫穿他整個職業生涯。在業界之外，賴正光也是熱心的慈善與學術推動者。他透過 Laygend Foundation 向加州大學聖地牙哥分校生物工程系捐贈資金，該系後來更以他與錢煦教授的名字命名為 Shu Chien-Gene Lay Department of Bioengineering。此外，他向 Brigham and Women’s Hospital、Massachusetts General Hospital 與 Harvard Medical School，共同成立 The Gene Lay Institute of Immunology and Inflammation，旨在推動免疫相關疾病與慢性炎症研究。

賴博士於 2016 年獲得聖地牙哥生命科學類別 EY Entrepreneur of the Year® Award，並同時成為該類別的全國決選入圍者。他擁有 University of Louisiana微生物/免疫學碩士以及國立屏東科技大學獸醫學院獸醫學博士（D.V.M.）。此外，他亦獲得國立屏東科技大學與國立陽明交通大學頒授之榮譽博士學位。並於 2025 年獲選為美國醫學與生物工程學會（AIMBE）Fellow。他也因卓越的創業精神與對全球生物醫學科研的貢獻，被視為台灣生技界的重要代表人物。

Dr. Gene Lay is Senior Vice President, Life Sciences at Revvity. As both a scientist and a strategic business leader, Gene leads a team responsible for shaping the Company’s Life Sciences portfolio and delivering solutions that accelerate breakthrough discoveries across therapeutic areas. Gene joined Revvity as part of the Company’s acquisition of BioLegend, the company he founded in June 2002 that’s recognized as a leader in the development of high-quality antibodies for cellular immunity. He served as the President and Chief Executive Officer of BioLegend since January 2003.

Gene has always been fascinated by the immune system’s ability to heal the body, and in 2023, he founded The Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School. Immunology and biomedical experts from the three institutions are working together to translate research discoveries into therapies for immune-related diseases rooted in chronic inflammation.

Prior to founding BioLegend, Gene co-founded PharMingen, Inc., a leading life science research reagents company, in 1987, where he served as Senior Vice President of Operations. In 1997, upon PharMingen’s acquisition by Becton, Dickinson and Company (BD Bioscience), Gene continued to serve as Vice President of Operations through 2002. Gene received the 2016 EY Entrepreneur of the Year® Award in San Diego in Life Sciences and was a National Finalist in the same category.

Gene received a Master of Science degree in Microbiology/Immunology from the University of Louisiana, Lafayette, and a Doctor of Veterinary Medicine (D.V.M.) from the Veterinary School at the National Pingtung University of Science and Technology in Taiwan. He holds honorary doctoral degrees from National Pingtung University of Science and Technology and National Yang Ming Chiao Tung University. The Fellow of American Institute of Medical and Biological Engineering (AIMBE) 2025.

停車訊息：